Nuveen’s iShares Biotechnology ETF IBB Stock Holding History

Nuveen’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$86.1K	Buy	+408	New	+$81.9K	﹤0.01%	4057
2018 Q3	–	Sell	-87,000	Closed	-$9.6M	–	1054
2018 Q2	$9.6M	Buy	87,000 +12,853	+17%	+$1.37M	0.06%	399
2018 Q1	$7.91M	Sell	74,147 -24,197	-25%	-$2.68M	0.05%	412
2017 Q4	$10.5M	Buy	+98,344	New	+$10.5M	0.07%	381
2017 Q2	–	Sell	-30,000	Closed	-$2.93M	–	1189
2017 Q1	$2.93M	Buy	+30,000	New	+$2.87M	0.02%	601
2016 Q4	–	Sell	-61,875	Closed	-$5.97M	–	1555
2016 Q3	$5.97M	Buy	+61,875	New	+$5.89M	0.03%	499

Other funds holding IBB

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

WestEnd Advisors Charlotte, North Carolina $4.53B AUM 12.98% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Nuveen's IBB Position: Q3 2026 in Review

Nuveen opened a new position in iShares Biotechnology ETF (IBB) in Q3 2026: 408 shares worth $86.1K. The stake represents ﹤0.01% of the portfolio and ranks #4057 among its holdings. This is a return to the name: Nuveen previously reported a position in IBB as recently as Q2 2018.

Nuveen first reported a position in IBB in Q3 2016 and has held it in 6 quarters since. The position peaked at $10.5M in Q4 2017. 681 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

Nuveen held 408 shares of iShares Biotechnology ETF worth $86.1K as of Q3 2026.
iShares Biotechnology ETF was a new Nuveen position in Q3 2026.
iShares Biotechnology ETF made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4057 holding.
Nuveen first reported a position in iShares Biotechnology ETF in Q3 2016 and has held it in 6 quarters since.
Nuveen's iShares Biotechnology ETF position peaked at $10.5M in Q4 2017.
681 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.